GenScript Biotech Corporation Expands Collaboration with Roche
PISCATAWAY, N.J., March 5, 2024 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript"), a global leader in life science research tools and services, is pleased to announce the expansion of their collaboration with Roche.
GenScript and Roche have had an ongoing collaboration since 2011 under a Laboratory Service Agreement relating to a suite of services and products from GenScript globally. GenScript and Roche have expanded their efforts and collaboration to drive innovation across the portfolio.
"We are thrilled to build upon our longstanding relationship with Roche," said Ray Chen, President of Life Science Group at GenScript. "This collaboration underscores our shared commitment to fostering groundbreaking developments in medical diagnostics. By combining our technological strengths, we are poised to offer unparalleled innovation that will ultimately benefit patients and customers worldwide."
Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced that Adrian Haigh has departed from his position as Fennec's Chief Operating Officer as of June 30, 2024. After nine years as an independent director,...
Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") , a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced today that its board of directors...
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that it will hold a mid-year corporate update to discuss recent positive developments in the NurOwn® program on...
Pope Francis hosted distinguished scientists and experts from various countries and disciplines at a private audience at the Apostolic Palace in Vatican City. The selected attendees were participants in the Three-day International Conference on...
LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, today announced the appointment of Staph Leavenworth Bakali as independent Chairman of its Board of Directors. Mr....
1 in 2 adults in the US have high blood pressure, and if you're over 55, the odds jump to 4 in 5. Given that heart attacks are the No.1 killer of men and women around the world, often precipitated by high blood...
